MRI-based imaging to guide treatment in nasopharyngeal cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study uses special MRI images (and computer “radiomics” scores) to better understand nasopharyngeal cancer. The goal is to help doctors choose the most appropriate treatment for people with newly diagnosed cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have newly diagnosed nasopharyngeal carcinoma that is confirmed by biopsy (non-keratinizing or keratinizing type)
- Your general health is good, with an ECOG score of 0–1 (able to carry out most daily activities)
- Your blood counts are adequate: white blood cells, hemoglobin, and platelets are above set minimums
- Your liver and kidneys are working well (liver tests within 2.5× normal; kidney function with creatinine clearance ≥60)
- You can have MRI scans safely and are able to follow the study plan
- You have not had chemotherapy or radiotherapy before (except certain limited exceptions for skin cancers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people with newly diagnosed nasopharyngeal cancer to test molecular (gene-related) markers and “spatial transcriptomics,” which maps which genes are active in different areas of the tumor. The goal is to better understand the cancer and find markers that could help guide future care.
This trial is for people with high-risk, newly diagnosed stage T3N1M0 nasopharyngeal cancer. It compares whether you need chemotherapy first (before radiation and chemotherapy together) to improve outcomes.
This study uses advanced testing (multi-omics) to predict if combining chemoradiation with immunotherapy works better for nasopharyngeal cancer that has returned or spread. It aims to find the right treatment for each person.
This trial tests a new computer-based tool (deep learning) to help diagnose a condition called sbORN (suspected benign or recurrent nasopharyngeal carcinoma) after radiation therapy. It aims to see if the tool can accurately tell if a suspicious spot is a recurrence or something harmless.
This trial tests a new type of radiation therapy that adjusts in real-time to treat nasopharyngeal cancer. It is for people who have not received prior radiation and have no distant spread of cancer.
This trial uses a combined PET/MRI scan to see if it can better detect how far your cancer has spread at first diagnosis. It is for people with locally advanced nasopharyngeal cancer who have not had treatment yet.
Hear when a new Nasopharyngeal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.